| Literature DB >> 29042603 |
Bin Jiang1, Xiaoqing Zhang1, Yongqiang Yuan1, Yuxiao Qu1, Zhibiao Feng2.
Abstract
An aqueous two-phase system (ATPS) consisting of poly(ethylene glycol-ran-propylene glycol) monobutyl ether (UCON)/phosphate was developed for the separation of the antioxidant peptides from pepsin hydrolysate of Whey Protein Isolate (WPI). The efficiency of the separation was evaluated based on the DPPH radical scavenging activity, ABTS radical scavenging activity and ferric reducing antioxidant power (FRAP) of the separated peptides. The effects of some parameters on the partition of antioxidant peptides were investigated. An efficient separation of antioxidant peptides was achieved using ATPS with pH of 4.0, 4 mL of UCON solution (40%, w/w), 4 mL of KH2PO4 solution (15.5%, w/w), 2 mL of WPI hydrolysate and 0.40 g/10 mL of NaCl. Reversed-phase high-performance liquid chromatography (RP-HPLC), amino acid analyzer and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) were used to characterize the purified peptides separated by the ATPS. The peptides in top phase were less polar than those in bottom phase. More antioxidative and hydrophobic amino acids were extracted to the top phase of ATPS, and the peptides with the amino acid sequences with antioxidant activities moved to the top phase as well. In conclusion, antioxidant peptides were successfully separated from the WPI hydrolysate by UCON/phosphate ATPS.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29042603 PMCID: PMC5645355 DOI: 10.1038/s41598-017-13507-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Effect of pH on the separation of peptides.
| Aqueous two-phase system variable | Top phase | Bottom phase | Volume ratio | Partition coefficient | ||
|---|---|---|---|---|---|---|
| Volume | Yield | Volume | Yield | |||
| UCON/KH2PO4 (pH = 4.00) | 4.0 ± 0.10c | 38.95 ± 0.56c | 6.0 ± 0.10a | 54.04 ± 0.38a | 0.67 ± 0.03c | 1.08 ± 0.04b |
| UCON/K2HPO4-KH2PO4 (pH = 6.00) | 4.6 ± 0.00b | 49.47 ± 0.83b | 5.4 ± 0.00b | 47.65 ± 0.74b | 0.85 ± 0.00b | 1.14 ± 0.01a |
| UCON/K2HPO4 (pH = 8.00) | 5.3 ± 0.10a | 54.40 ± 0.68a | 4.7 ± 0.10c | 40.67 ± 0.58c | 1.13 ± 0.05a | 1.19 ± 0.03a |
1The data (mean ± standard deviation) derived from 3 replicates as described in the Materials and Methods section.
2The difference between the mean values with the same superscript letter in the same column was significant at a 95% confidence interval.
Figure 1Effect of pH on the separation of antioxidant peptides. (a) DPPH radical scavenging activity; (b) ABTS radical scavenging activity; (c) ferric reducing antioxidant power (FRAP).
Effect of the ratio of the volumes of UCON and KH2PO4 on the separation of peptides.
| Aqueous two-phase system variable | Top phase | Bottom phase | Volume ratio | Partition coefficient | ||
|---|---|---|---|---|---|---|
| Volume | Yield | Volume | Yield | |||
| 5 mL:3 mL | 5.8 ± 0.00a | 49.54 ± 0.56a | 4.2 ± 0.00b | 36.34 ± 0.30c | 1.38 ± 0.00a | 0.99 ± 0.13a |
| 4 mL:4 mL | 4.0 ± 0.10b | 38.95 ± 0.56b | 6.0 ± 0.10a | 54.04 ± 0.38b | 0.67 ± 0.03b | 1.08 ± 0.04a |
| 3 mL:5 mL | 3.8 ± 0.20b | 38.73 ± 0.72b | 6.2 ± 0.20a | 62.00 ± 0.80a | 0.61 ± 0.05b | 1.02 ± 0.02a |
1The data (mean ± standard deviation) derived from 3 replicates as described in the Materials and Methods section.
2The difference between the mean values with the same superscript letter in the same column was significant at a 95% confidence interval.
Figure 2Effect of the ratio of the volumes of UCON and KH2PO4 on the separation of antioxidant peptides. (a) DPPH radical scavenging activity; (b) ABTS radical scavenging activity; (c) ferric reducing antioxidant power (FRAP).
Effect of NaCl on the separation of peptides.
| Aqueous two-phase system variable | Top phase | Bottom phase | Volume ratio | Partition coefficient | ||
|---|---|---|---|---|---|---|
| Volume | Yield | Volume | Yield | |||
| NaCl = 0 g/10mL | 6.5 ± 0.00a | 52.36 ± 0.87a | 3.5 ± 0.00b | 38.59 ± 0.60b | 1.86 ± 0.00a | 0.74 ± 0.06b |
| NaCl = 0.40 g/10mL | 4.0 ± 0.10b | 38.95 ± 0.56b | 6.0 ± 0.10a | 54.04 ± 0.38a | 0.67 ± 0.03b | 1.08 ± 0.04a |
1The data (mean ± standard deviation) derived from 3 replicates as described in the Materials and Methods section.
2The difference between the mean values with the same superscript letter in the same column was significant at a 95% confidence interval.
Effect of NaCl on the separation of antioxidant peptides.
| Aqueous two-phase system variable | DPPH (%) | ABTS | FRAP | |
|---|---|---|---|---|
| NaCl = 0 g/10mL | Top phase | 32.93 ± 0.07c | 42.51 ± 0.91b | 0.12 ± 0.00e |
| Bottom phase | 22.04 ± 0.28d | 25.14 ± 0.16c | 0.29 ± 0.01b | |
| NaCl = 0.40 g/10mL | Top phase | 64.77 ± 0.13a | 52.04 ± 0.11a | 0.37 ± 0.02a |
| Bottom phase | 18.91 ± 0.53e | 14.47 ± 0.26e | 0.19 ± 0.01d | |
| WPI hydrolysate | 49.53 ± 0.52b | 23.45 ± 0.19d | 0.24 ± 0.00c |
1The data (mean ± standard deviation) derived from 3 replicates as described in the Materials and Methods section.
2The difference between the mean values with the same superscript letter in the same column was significant at a 95% confidence interval.
Figure 3RP-HPLC analysis of the peptides. (a) RP-HPLC chromatograms of the WPI hydrolysate, top phase and purified peptides from the top phase, b: RP-HPLC chromatograms of the WPI hydrolysate, bottom phase and purified peptides from the bottom phase.
Comparison of the types and content of amino acids.
| Types of amino acids | The contents of amino acids in the WPI hydrolysate (%) | The contents of amino acids in the purified peptides from top phase (%) | The change of contents of amino acids (%) | The contents of amino acids in the purified peptides from bottom phase (%) | The change of contents of amino acids (%) |
|---|---|---|---|---|---|
| Aspartic acid | 11.16 | 10.85 | −0.31 | 12.35 | +1.19 |
| Threonine | 8.78 | 4.55 | −4.23 | 9.07 | +0.29 |
| Serine | 5.27 | 3.62 | −1.65 | 5.83 | +0.56 |
| Glutamic acid | 16.55 | 17.55 | +1 | 21.22 | +4.67 |
| Glycine | 2.37 | 1.18 | −1.19 | 1.60 | −0.77 |
| Alanine | 4.63 | 4.39 | −0.24 | 3.13 | −1.5 |
| Cystine | 1.73 | 5.61 | +3.88 | 1.71 | −0.02 |
| Valine | 5.45 | 5.69 | +0.24 | 4.13 | −1.32 |
| Methionine | 2.12 | 1.18 | −0.94 | 1.50 | −0.62 |
| Isoleucine | 6.21 | 5.69 | −0.53 | 8.34 | +2.12 |
| Leucine | 10.93 | 9.31 | −1.62 | 6.27 | −4.66 |
| Tyrosine | 3.25 | 5.24 | +1.99 | 1.97 | −1.28 |
| Phenylalanine | 2.56 | 6.95 | +4.39 | 2.12 | −0.44 |
| Lysine | 9.07 | 11.34 | +2.27 | 8.84 | −0.23 |
| Histidine | 1.52 | 2.44 | +0.92 | 1.32 | −0.2 |
| Argnine | 1.96 | 0.96 | −1 | 1.41 | −0.55 |
| Proline | 6.43 | 3.45 | −2.98 | 9.19 | +2.76 |
Figure 4MALDI-TOF MS analysis of purified peptides. (a) MALDI-TOF spectrum of purified peptides from the WPI hydrolysate; (b) MALDI-TOF spectrum of purified peptides from the top phase; (c) MALDI-TOF spectrum of purified peptides from the bottom phase.
Amino acid sequences of peptides from different phases.
| The source of the peptides | Protein fragment | observed m/z | calculated m/z | Amino acid sequences | Peptide having antioxidant activity |
|---|---|---|---|---|---|
| bottom phase | β-Lg 27–32 | 670.74 | 672.7795 | DIQKVA | |
| hydrolysate | β-Lg 153–159 | 758.531 | 757.9285 | DKALKAL | |
| top phase | β-Lg 173–178 | 758.558 | 757.8163 | EEQCHI | |
| hydrolysate | β-Lg 56–61 | 791.634 | 793.875 | RVYVEE | |
| top phase | β-Lg 144–150 | 791.638 | 789.7943 | VDDEALE | |
| top phase | β-Lg 27–38 | 1381.72 | 1380.5633 | DIQKVAGTWYSL | WY |
| WYS | |||||
| hydrolysate | β-Lg 22–35 | 1545.457 | 1547.8328 | TMKGLDIQKVAGTW | |
| top phase | β-Lg 82–96 | 1641.930 | 1642.0331 | CAQKKIIAEKTKIPA | |
| hydrolysate | β-Lg 104–118 | 1844.441 | 1842.079 | NENKVLVLDTDYKKY | VLVLDTDYK |
| top phase | 1845.058 | ||||
| hydrolysate | β-Lg 82–98 | 1884.995 | 1888.3423 | CAQKKIIAEKTKIPAVF | KTKIPAVF |
| top phase | 1885.041 | IPAVF | |||
| hydrolysate | β-Lg 18–35 | 1989.167 | 1989.3606 | IVTQTMKGLDIQKVAGTW | |
| top phase | 1989.012 | ||||
| bottom phase | β-Lg 42–50 | 903.708 | 903.9847 | ASDISLLDA | KTKIPAVF |
| β-Lg 91–98 | 903.1327 | KTKIPAVF | IPAVF | ||
| bottom phase | β-Lg 78–90 | 1433.787 | 1432.6116 | ENGECAQKKIIAE | |
| bottom phase | α-La 45–58 | 1647.948 | 1646.7708 | WVCTTFHTSGYDTQ | |
| β-Lg 134–148 | 1648.8233 | ACQCLVRTPEVDDEA | |||
| hydrolysate | α-La32–50 | 2102.247 | 2101.4244 | KDLKGYGGVSLPEWVCTTF | |
| bottom phase | β-Lg17–35 | 2102.569 | 2102.5200 | LIVTQTMKGLDIQKVAGTW | |
| bottom phase | α-La 45–62 | 2061.068 | 2058.2723 | WVCTTFHTSGYDTQAIVQ | |
| bottom phase | β-Lg 84–102 | 2139.356 | 2141.6256 | QKKIIAEKTKIPAVFKIDA | KTKIPAVF |
| β-Lg 91–109 | 2141.5822 | KTKIPAVFKIDALNENKVL | IPAVF | ||
| bottom phase | α-La51–69 | 2247.202 | 2144.1719 | HTSGYDTQAIVQNNDSTEY | |
| hydrolysate | β-Lg 49–58 | 1119.585 | 1119.2426 | DAQSAPLRVY | YVEEL[ |
| β-Lg 43–53 | 1119.1936 | SDISLLDAQSA | |||
| hydrolysate | β-Lg 48–58 | 1232.665 | 1232.402 | LDAQSAPLRVY | |
| α-La 70–79 | 1233.455 | GLFQINNKIW | |||
| hydrolysate | α-La116–128 | 1514.768 | 1515.7545 | DKVGINYWLAHKA |